Gallbladder Carcinoma — Trials

Gallbladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

56 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 18
Recruiting: 8
Ph III recruiting: 1
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07146646	Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer	recruiting	Phase 2	27	Case Comprehensive Cancer CenterOTHER	1	Sep 22, 2026	clinicaltrials
NCT07780838	Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma	recruiting	Phase 2	29	Ohio State University Comprehensive Cancer CenterOTHER	1	Sep 10, 2026	clinicaltrials